Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Xiang, Xianyuan"" wg kryterium: Autor


Wyświetlanie 1-10 z 10
Tytuł :
The Alzheimer’s disease-associated protective Plcγ2-P522R variant promotes immune functions
Autorzy :
Takalo, Mari
Wittrahm, Rebekka
Wefers, BenediktAff2, Aff3
Parhizkar, Samira
Jokivarsi, Kimmo
Kuulasmaa, Teemu
Mäkinen, Petra
Martiskainen, Henna
Wurst, WolfgangAff2, Aff3, Aff6
Xiang, Xianyuan
Marttinen, MikaelAff1, Aff7
Poutiainen, Pekka
Haapasalo, Annakaisa
Hiltunen, Mikko
Haass, ChristianAff2, Aff4, Aff6
Pokaż więcej
Źródło :
Molecular Neurodegeneration. 15(1)
Czasopismo naukowe
Tytuł :
The Trem2 R47H Alzheimer’s risk variant impairs splicing and reduces Trem2 mRNA and protein in mice but not in humans
Autorzy :
Xiang, XianyuanAff1, Aff2
Piers, Thomas M.
Wefers, BenediktAff4, Aff6
Zhu, KaichuanAff4, Aff5
Mallach, Anna
Brunner, Bettina
Kleinberger, GernotAff1, Aff5
Song, Wilbur
Colonna, Marco
Herms, JochenAff4, Aff5, Aff8
Wurst, WolfgangAff4, Aff5, Aff6, Aff9
Pocock, Jennifer M.
Haass, ChristianAff1, Aff4, Aff5
Pokaż więcej
Źródło :
Molecular Neurodegeneration. 13(1)
Czasopismo naukowe
Tytuł :
White matter aging drives microglial diversity.
Autorzy :
Safaiyan, Shima (AUTHOR)
Besson-Girard, Simon (AUTHOR)
Kaya, Tuğberk (AUTHOR)
Cantuti-Castelvetri, Ludovico (AUTHOR)
Liu, Lu (AUTHOR)
Ji, Hao (AUTHOR)
Schifferer, Martina (AUTHOR)
Gouna, Garyfallia (AUTHOR)
Usifo, Fumere (AUTHOR)
Kannaiyan, Nirmal (AUTHOR)
Fitzner, Dirk (AUTHOR)
Xiang, Xianyuan (AUTHOR)
Rossner, Moritz J. (AUTHOR)
Brendel, Matthias (AUTHOR)
Gokce, Ozgun (AUTHOR)
Simons, Mikael (AUTHOR)
Pokaż więcej
Źródło :
Neuron. Apr2021, Vol. 109 Issue 7, p1100-1100. 1p.
Czasopismo naukowe
Tytuł :
Pre-therapeutic microglia activation and sex determine therapy effects of chronic immunomodulation.
Autorzy :
Biechele G; Dept. of Nuclear Medicine, University Hospital of Munich, LMU Munich, Munich, Germany.
Blume T; Dept. of Nuclear Medicine, University Hospital of Munich, LMU Munich, Munich, Germany.; DZNE - German Center for Neurodegenerative Diseases, Munich, Germany.
Deussing M; Dept. of Nuclear Medicine, University Hospital of Munich, LMU Munich, Munich, Germany.
Zott B; Institute of Neuroscience, Technical University of Munich, Munich, Germany.; Department of Diagnostic and Interventional Neuroradiology, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany.
Shi Y; DZNE - German Center for Neurodegenerative Diseases, Munich, Germany.
Xiang X; Metabolic Biochemistry, Biomedical Center (BMC), Faculty of Medicine, Ludwig-Maximilians-Universität München, Munich, Germany.
Franzmeier N; Institute for Stroke and Dementia Research, University Hospital of Munich, LMU Munich, Munich, Germany.
Kleinberger G; ISAR Bioscience GmbH, 82152 Planegg, Germany.
Peters F; DZNE - German Center for Neurodegenerative Diseases, Munich, Germany.
Ochs K; DZNE - German Center for Neurodegenerative Diseases, Munich, Germany.
Focke C; Dept. of Nuclear Medicine, University Hospital of Munich, LMU Munich, Munich, Germany.
Sacher C; Dept. of Nuclear Medicine, University Hospital of Munich, LMU Munich, Munich, Germany.
Wind K; Dept. of Nuclear Medicine, University Hospital of Munich, LMU Munich, Munich, Germany.
Schmidt C; Dept. of Nuclear Medicine, University Hospital of Munich, LMU Munich, Munich, Germany.
Lindner S; Dept. of Nuclear Medicine, University Hospital of Munich, LMU Munich, Munich, Germany.
Gildehaus FJ; Dept. of Nuclear Medicine, University Hospital of Munich, LMU Munich, Munich, Germany.
Eckenweber F; Dept. of Nuclear Medicine, University Hospital of Munich, LMU Munich, Munich, Germany.
Beyer L; Dept. of Nuclear Medicine, University Hospital of Munich, LMU Munich, Munich, Germany.
von Ungern-Sternberg B; Dept. of Nuclear Medicine, University Hospital of Munich, LMU Munich, Munich, Germany.
Bartenstein P; Dept. of Nuclear Medicine, University Hospital of Munich, LMU Munich, Munich, Germany.; SyNergy, University of Munich, Munich, Germany.
Baumann K; Roche Pharma Research and Early Development, Neuroscience Discovery, Roche, Innovation Center Basel, F. Hoffmann-La Roche Ltd., Basel, Switzerland.
Dorostkar MM; DZNE - German Center for Neurodegenerative Diseases, Munich, Germany.; Center for Neuropathology and Prion Research, Ludwig-Maximilians-University of Munich, Munich, Germany.
Rominger A; Dept. of Nuclear Medicine, University Hospital of Munich, LMU Munich, Munich, Germany.; SyNergy, University of Munich, Munich, Germany.; Dept. of Nuclear Medicine, Inselspital Bern, Bern, Switzerland.
Cumming P; Dept. of Nuclear Medicine, Inselspital Bern, Bern, Switzerland.; School of Psychology and Counselling, Queensland University of Technology, Brisbane, Australia.
Willem M; Metabolic Biochemistry, Biomedical Center (BMC), Faculty of Medicine, Ludwig-Maximilians-Universität München, Munich, Germany.
Adelsberger H; Institute of Neuroscience, Technical University of Munich, Munich, Germany.
Herms J; DZNE - German Center for Neurodegenerative Diseases, Munich, Germany.; SyNergy, University of Munich, Munich, Germany.; Center for Neuropathology and Prion Research, Ludwig-Maximilians-University of Munich, Munich, Germany.
Brendel M; Dept. of Nuclear Medicine, University Hospital of Munich, LMU Munich, Munich, Germany.; SyNergy, University of Munich, Munich, Germany.
Pokaż więcej
Źródło :
Theranostics [Theranostics] 2021 Aug 19; Vol. 11 (18), pp. 8964-8976. Date of Electronic Publication: 2021 Aug 19 (Print Publication: 2021).
Typ publikacji :
Journal Article
Czasopismo naukowe
    Wyświetlanie 1-10 z 10

    Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies